JP2015500841A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015500841A5 JP2015500841A5 JP2014547630A JP2014547630A JP2015500841A5 JP 2015500841 A5 JP2015500841 A5 JP 2015500841A5 JP 2014547630 A JP2014547630 A JP 2014547630A JP 2014547630 A JP2014547630 A JP 2014547630A JP 2015500841 A5 JP2015500841 A5 JP 2015500841A5
- Authority
- JP
- Japan
- Prior art keywords
- ester
- simnol
- pharmaceutically acceptable
- seborrhea
- dermal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000002148 esters Chemical class 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 4
- 206010039792 Seborrhoea Diseases 0.000 claims 3
- 230000002500 effect on skin Effects 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 208000008742 seborrheic dermatitis Diseases 0.000 claims 3
- 230000000699 topical effect Effects 0.000 claims 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 229910052708 sodium Inorganic materials 0.000 claims 2
- 239000011734 sodium Substances 0.000 claims 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229910052938 sodium sulfate Inorganic materials 0.000 claims 1
- 235000011152 sodium sulphate Nutrition 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2011905331 | 2011-12-20 | ||
| AU2011905331A AU2011905331A0 (en) | 2011-12-20 | Treatment of seborrhoea | |
| AU2012900670A AU2012900670A0 (en) | 2012-02-22 | Treatment of seborrhoea | |
| AU2012900670 | 2012-02-22 | ||
| PCT/AU2012/001543 WO2013090986A1 (en) | 2011-12-20 | 2012-12-14 | Treatment of seborrhoea |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015500841A JP2015500841A (ja) | 2015-01-08 |
| JP2015500841A5 true JP2015500841A5 (enExample) | 2016-02-12 |
Family
ID=48667492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014547630A Pending JP2015500841A (ja) | 2011-12-20 | 2012-12-14 | 脂漏症の治療 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20140364405A1 (enExample) |
| EP (1) | EP2793897B1 (enExample) |
| JP (1) | JP2015500841A (enExample) |
| KR (1) | KR20140120890A (enExample) |
| CN (1) | CN104144689A (enExample) |
| AU (1) | AU2012321108B2 (enExample) |
| BR (1) | BR112014014968A2 (enExample) |
| CA (1) | CA2859826A1 (enExample) |
| DK (1) | DK2793897T3 (enExample) |
| ES (1) | ES2632591T3 (enExample) |
| HU (1) | HUE033800T2 (enExample) |
| IN (1) | IN2014CN04693A (enExample) |
| MX (1) | MX2014007659A (enExample) |
| MY (1) | MY165030A (enExample) |
| PL (1) | PL2793897T3 (enExample) |
| PT (1) | PT2793897T (enExample) |
| RU (1) | RU2624238C2 (enExample) |
| SG (1) | SG11201403078RA (enExample) |
| WO (1) | WO2013090986A1 (enExample) |
| ZA (1) | ZA201404348B (enExample) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA876171B (en) * | 1986-08-21 | 1988-10-26 | Broadbent James Meredyth | Active principle isolated from shark tissue |
| ZA947912B (en) * | 1993-10-12 | 1995-05-24 | Broadbent J W Nominees Pty Ltd | Treatment of medical disorders associated with free radical formation |
| JP2007063139A (ja) * | 2005-08-29 | 2007-03-15 | Daicho Kikaku:Kk | 皮膚用剤 |
| JP2007244325A (ja) * | 2006-03-17 | 2007-09-27 | Daicho Kikaku:Kk | 新しい健康食品 |
-
2012
- 2012-12-14 HU HUE12859788A patent/HUE033800T2/en unknown
- 2012-12-14 AU AU2012321108A patent/AU2012321108B2/en active Active
- 2012-12-14 BR BR112014014968A patent/BR112014014968A2/pt not_active Application Discontinuation
- 2012-12-14 MY MYPI2014001674A patent/MY165030A/en unknown
- 2012-12-14 JP JP2014547630A patent/JP2015500841A/ja active Pending
- 2012-12-14 MX MX2014007659A patent/MX2014007659A/es unknown
- 2012-12-14 SG SG11201403078RA patent/SG11201403078RA/en unknown
- 2012-12-14 CN CN201280063798.3A patent/CN104144689A/zh active Pending
- 2012-12-14 US US14/366,261 patent/US20140364405A1/en not_active Abandoned
- 2012-12-14 RU RU2014126635A patent/RU2624238C2/ru active
- 2012-12-14 WO PCT/AU2012/001543 patent/WO2013090986A1/en not_active Ceased
- 2012-12-14 KR KR1020147020089A patent/KR20140120890A/ko not_active Withdrawn
- 2012-12-14 ES ES12859788.7T patent/ES2632591T3/es active Active
- 2012-12-14 CA CA2859826A patent/CA2859826A1/en not_active Abandoned
- 2012-12-14 PL PL12859788T patent/PL2793897T3/pl unknown
- 2012-12-14 DK DK12859788.7T patent/DK2793897T3/en active
- 2012-12-14 IN IN4693CHN2014 patent/IN2014CN04693A/en unknown
- 2012-12-14 PT PT128597887T patent/PT2793897T/pt unknown
- 2012-12-14 EP EP12859788.7A patent/EP2793897B1/en active Active
-
2014
- 2014-06-12 ZA ZA2014/04348A patent/ZA201404348B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013542247A5 (enExample) | ||
| HRP20191957T1 (hr) | Policiklični-karbamoilpiridonski spojevi i njihova farmaceutska upotreba | |
| CY1119490T1 (el) | Παραγωγα πυραζολοπυρρολιδινης και η χρηση τους στην θεραπεια νοσηματων | |
| HRP20240168T1 (hr) | Kombinacije dolutegravira i lamivudina za liječenje hiv infekcije | |
| JP2012255026A5 (enExample) | ||
| JP2014521735A5 (enExample) | ||
| HRP20180237T4 (hr) | Metode za liječenje hcv-a | |
| EA201592256A1 (ru) | Производные имидазопирролидинона и их применение при лечении заболеваний | |
| JP2011201907A5 (enExample) | ||
| WO2013101897A3 (en) | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid | |
| EA201491479A1 (ru) | Производные лупановых тритерпеноидов и их фармацевтическое применение | |
| HRP20250119T1 (hr) | Kdm1a inhibitor i njegova primjena u terapiji | |
| JP2012532874A5 (enExample) | ||
| JP2013520405A5 (enExample) | ||
| HRP20171512T1 (hr) | Derivati betulina | |
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| HRP20171648T1 (hr) | Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze | |
| EA201592255A1 (ru) | Производные пиразолопирролидин-4-она в качестве ингибиторов вет и их применение при лечении заболевания | |
| JP2015534562A5 (enExample) | ||
| EA201792597A2 (ru) | Производные глутаримидов, их применение, фармацевтическая композиция на их основе, способы их получения | |
| JP2013541583A5 (enExample) | ||
| JP2015516419A5 (enExample) | ||
| ME02405B (me) | Spojevi pirazola као inhibitori sglt1 | |
| NZ611026A (en) | Pharmaceutical composition comprising citrate and bicarbonate salts, and use thereof for treating cystinuria | |
| JP2014509637A5 (enExample) |